<SEC-DOCUMENT>0001628280-18-000648-index.html : 20180129
<SEC-HEADER>0001628280-18-000648.hdr.sgml : 20180129
<ACCEPTANCE-DATETIME>20180129101451
ACCESSION NUMBER:		0001628280-18-000648
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20180126
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180129
DATE AS OF CHANGE:		20180129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Menlo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001566044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				453757789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38356
		FILM NUMBER:		18553789

	BUSINESS ADDRESS:	
		STREET 1:		4085 CAMPBELL AVENUE, SUITE 200
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-486-1416

	MAIL ADDRESS:	
		STREET 1:		4085 CAMPBELL AVENUE, SUITE 200
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tigercat Pharma, Inc.
		DATE OF NAME CHANGE:	20130104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>menlo8-k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: menlo8-k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>exhibit31.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
Document 2 - file: exhibit31.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>exhibit32.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
Document 3 - file: exhibit32.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 4 - file: exhibit991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>exhibit992.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
Document 5 - file: exhibit992.htm

</DOCUMENT>
</SEC-DOCUMENT>